Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott M Berry

Showing results (11-20 of 113) with videos related to

Pageof 12
Sort By:
Lab on a Chip|March 23, 2011
One-step purification of nucleic acid for gene expression analysis via Immiscible Filtration Assisted by Surface Tension (IFAST)Scott M Berry, Elaine T Alarid, David J Beebe
Journal of Biopharmaceutical Statistics|January 22, 2013
Combining risk difference and risk ratio in noninferiority trials of safetyKristine R Broglio, Jason T Connor, Scott M Berry
Cancer Investigation|April 8, 2011
Addressing the incremental benefit of histamine dihydrochloride when added to interleukin-2 in treating acute myeloid leukemia: a Bayesian meta-analysisScott M Berry, Kristine R Broglio, Donald A Berry
Journal of Biopharmaceutical Statistics|April 5, 2014
Not too big, not too small: a goldilocks approach to sample size selectionKristine R Broglio, Jason T Connor, Scott M Berry
Pharmaceutical Statistics|April 27, 2024
Optimal sample size division in two-stage seamless designsLindsay R Berry, Joe Marion, Scott M Berry, et al.
Contemporary Clinical Trials|July 15, 2015
Bayesian dose escalation in oncology with sharing of information between patient populationsKristine R Broglio, Larissa Sandalic, Tina Albertson, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 3, 2022
Platform trials as the way forward in infectious disease' clinical research: the case of coronavirus disease 2019Juan M Pericàs, Lennie P G Derde, Scott M Berry, et al.
Clinical Trials (London, England)|August 29, 2013
Bayesian hierarchical modeling of patient subpopulations: efficient designs of Phase II oncology clinical trialsScott M Berry, Kristine R Broglio, Susan Groshen, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro|November 4, 2017
RNA-mediated TILDA for improved cell capacity and enhanced detection of multiply-spliced HIV RNAHannah M Pezzi, Scott M Berry, David J Beebe, et al.
American Heart Journal|June 11, 2003
Comparison of the dose-response relationships of 2 lipid-lowering agents: a Bayesian meta-analysisDonald A Berry, Scott M Berry, John McKellar, et al.
Pageof 12

Showing results (11-20 of 113) with videos related to

Sort By:
Pageof 12
Lab on a Chip|March 23, 2011
One-step purification of nucleic acid for gene expression analysis via Immiscible Filtration Assisted by Surface Tension (IFAST)Scott M Berry, Elaine T Alarid, David J Beebe
Journal of Biopharmaceutical Statistics|January 22, 2013
Combining risk difference and risk ratio in noninferiority trials of safetyKristine R Broglio, Jason T Connor, Scott M Berry
Cancer Investigation|April 8, 2011
Addressing the incremental benefit of histamine dihydrochloride when added to interleukin-2 in treating acute myeloid leukemia: a Bayesian meta-analysisScott M Berry, Kristine R Broglio, Donald A Berry
Journal of Biopharmaceutical Statistics|April 5, 2014
Not too big, not too small: a goldilocks approach to sample size selectionKristine R Broglio, Jason T Connor, Scott M Berry
Pharmaceutical Statistics|April 27, 2024
Optimal sample size division in two-stage seamless designsLindsay R Berry, Joe Marion, Scott M Berry, et al.
Contemporary Clinical Trials|July 15, 2015
Bayesian dose escalation in oncology with sharing of information between patient populationsKristine R Broglio, Larissa Sandalic, Tina Albertson, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 3, 2022
Platform trials as the way forward in infectious disease' clinical research: the case of coronavirus disease 2019Juan M Pericàs, Lennie P G Derde, Scott M Berry, et al.
Clinical Trials (London, England)|August 29, 2013
Bayesian hierarchical modeling of patient subpopulations: efficient designs of Phase II oncology clinical trialsScott M Berry, Kristine R Broglio, Susan Groshen, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro|November 4, 2017
RNA-mediated TILDA for improved cell capacity and enhanced detection of multiply-spliced HIV RNAHannah M Pezzi, Scott M Berry, David J Beebe, et al.
American Heart Journal|June 11, 2003
Comparison of the dose-response relationships of 2 lipid-lowering agents: a Bayesian meta-analysisDonald A Berry, Scott M Berry, John McKellar, et al.
Pageof 12